Imaging Core
Imaging Core
批准号:
8291336
负责人:
Anna M Wu
金额:
$9.41万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2013-06-30
关键词:
AnimalsAntibodiesArchivesAreaAutoradiographyAwardBehaviorBiologicalBiological MarkersBioluminescenceBuild-itCaliforniaCancer DetectionCapromab PendetideCardiologyCell NucleusCell ProliferationCell surfaceClinicClinicalCommunitiesComprehensive Cancer CenterConsultationsDataDatabasesDepartment of EnergyDetectionDevelopmentDiscipline of Nuclear MedicineDiseaseDoctor of MedicineEnsureEvaluationExcretory functionFacultyFluorescenceFundingGene DeliveryGenesGlucoseGlutamate Carboxypeptidase IIGoalsGrantHousingImageImage AnalysisImaging TechniquesImaging technologyInstitutesInvestigationKnowledgeLabelLaboratoriesLeadershipLearningMagnetic Resonance ImagingMainstreamingMalignant NeoplasmsMalignant neoplasm of prostateMedical ResearchMedical centerMetabolicModelingMolecularMolecular MedicineMonitorMusNeurologyOrganismPET/CT scanParticipantPathway interactionsPatientsPelvisPhysiciansPlayPositioning AttributePositron-Emission TomographyPostdoctoral FellowPre-Clinical ModelProstateQuality ControlRadiolabeledRadionuclide ImagingReporterResearchResearch PersonnelResourcesRetrievalRodentRoleScheduleScienceSensitivity and SpecificityServicesSmall Animal Imaging Resource ProgramsSmall Animal Imaging SystemsSodiumStagingSystemTechnologyTherapeutic AgentsTimeTracerTrainingTransgenic OrganismsUltrasonographyWorkXenograft procedureantibody engineeringbasebonecryostatdigitaleffective therapyfluorescence imagingimaging modalityimprovedin vivoin vivo Cellular and Molecular Imaging Centersinnovationinstrumentinstrumentationinterestinvestigator trainingmedical schoolsmolecular imagingmolecular/cellular imagingmouse modelnanosystemsnoveloncologyoptical imagingpre-clinicalpre-clinical researchprogramsradiotracerresearch clinical testingresponsesingle photon emission computed tomographytreatment planninguptakeurinaryvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Imaging Core is to support the in vivo imaging needs of the projects of the UCLA
SPORE in Prostate Cancer. Non-invasive imaging is a key experimental approach for studying disease in
intact organisms. The Imaging Core provides functional as well as anatomical imaging technologies to
SPORE investigators, at the pre-clinical and clinical level. Furthermore, the Core works closely with
investigators to develop and implement new imaging tracers and technologies. Finally, centralization of
these services in a Core improves the quality and reliability of imaging-based data. The goals of the Imaging
Core are : 1) to provide and support state-of-the-art small animal preclinical imaging research; 2) to support
innovative clinical imaging studies; and 3) to provide scientific and administrative support to Prostate
SPORE investigators. Pre-clinical imaging studies are centralized in the Crump Institute imaging facility,
which houses two microPET scanners, a microCT, three Xenogen IVIS optical imaging system, and a new
Maestro multispectral fluorescence imager. Ancillary facilities including radiolabeling lab and rodent housing,
are adjacent. In 2007 the preclinical Imaging Facility will relocate to new, spacious quarters in the California
Nanosystems Institute building where it will continue to expand its offerings to investigators in oncologic
molecular imaging. Clinical imaging and evaluation of novel radiolabeled tracers is supported by the
Ahmanson Biological Imaging Clinic in the Geffen School of Medicine. Key aspects of the provision of
imaging services are quality control and data acquision/storage/analysis, which the Imaging Core provides in
order to ensure reliable access to the instrumentation and data. Lay description: One of the most exciting
areas of medical research is the developing of new ways to "see" what's going on, in pre-clinical models, and
ultimately in patients. Molecular imaging will provide better ways to detect cancer, and smarter ways to
understand its behavior and select the most effective therapy. The Imaging Core helps all SPORE
investigators to integrate imaging into their basic investigations, and to develop new ways to detect prostate
cancer in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
-
批准号:10544038
-
项目类别:
-
资助金额:$71.49万
-
财政年份:2022
-
负责人:Anna M Wu
-
依托单位:
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
-
批准号:10343450
-
项目类别:
-
资助金额:$73.0万
-
财政年份:2022
-
负责人:Anna M Wu
-
依托单位:
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet
-
批准号:8928583
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2014
-
负责人:Anna M Wu
-
依托单位:
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet
-
批准号:8791842
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2014
-
负责人:Anna M Wu
-
依托单位:
In vivo imaging of T Cells using engineered antibodies and PET
-
批准号:8786848
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2014
-
负责人:Anna M Wu
-
依托单位:
Cancer Molecular Imaging
-
批准号:7944543
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2009
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:7315097
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2007
-
负责人:Anna M Wu
-
依托单位:
Recombinant Carcinoembronic Antigen as PET Reporter Gene
-
批准号:7039880
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2005
-
负责人:Anna M Wu
-
依托单位:
Biological Modification of Quantum Dots for in vivo Imaging
-
批准号:7067899
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2005
-
负责人:Anna M Wu
-
依托单位:
High-avidity multimeric cancer imaging agent
-
批准号:6829532
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2004
-
负责人:Anna M Wu
-
依托单位:
High-avidity multimeric cancer imaging agent
-
批准号:6931073
-
项目类别:
-
资助金额:$19.02万
-
财政年份:2004
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:8555102
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:8924997
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:7679553
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:8760365
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:7879473
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
Imaging Core
-
批准号:8094365
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2002
-
负责人:Anna M Wu
-
依托单位:
BIOENGINEERED ANTIBODIES
-
批准号:6300284
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2000
-
负责人:Anna M Wu
-
依托单位:
BIOENGINEERED ANTIBODIES
-
批准号:6102344
-
项目类别:
-
资助金额:$15.65万
-
财政年份:1999
-
负责人:Anna M Wu
-
依托单位:
BIOENGINEERED ANTIBODIES
-
批准号:6269268
-
项目类别:
-
资助金额:$23.57万
-
财政年份:1998
-
负责人:Anna M Wu
-
依托单位:
海外基金